Add To Watchlist
Share URL
About The Company
CEO
Mr. Richard D. Francis
Market Cap
15.82 Billion USD
Sector
Healthcare
Website
https://www.tevapharm.comLast Update
2/22/2024, 12:00:00 PM
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally.
Read More
Overview
Value
15
Growth
20
Health
32
Management
0
Analyst Opinion
77
Total
36
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Has a high level of debt
- Altman-Z score suggests a risk of bankruptcy
- Disliked by Twitter users
- Poor earnings and cashflow growth
- Dividend could be at risk
Market Peers
TEVA
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Buy
Share Buybacks
N/A
Dividend Yeild (TTM)
0.00%
Valuation
Value Score
15
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 9.4 USD ✘
Current Price: 13.7 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
5.50%
PE/Earnings Growth
N/A
Price/Book
1.88x
Growth
Growth Score
20
- ✔ Revenue growth has improved this yeara
- ✔ Earnings growth has improved this year
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
N/A
Earnings Growth
N/A
Cashflow Growth
N/A
Health
Health Score
32
Altman Z Score
0.43
Piostroski Score
5.00
Debt/Equity
2.28x
Current Assets/Liabilities
1.14x
Free Cashflow/Total Debt
0.01x
Debt/Capital
1.87x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of 0.00% is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
0.00%
Dividend Growth
N/A
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
0
Average Buybacks/Dilution
N/A
Recent Buybacks/Dilution
1.72%
5 Year Price Volitility
11.06%
Return On Assets
0.89%
Return On Capital Employed
7.12%
Return On Equity
4.14%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
77
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Teva Pharmaceutical Industries Limited
Currency
USD
Beta
1.187158
Vol Avg
13318654
Ceo
Mr. Richard D. Francis
Cik
0000818686
Cusip
881624209
Exchange
New York Stock Exchange
Full Time Employees
34004
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
1982-02-16
Address
124 Dvora Hanevi’a Street
City
Tel Aviv
State
Country
IL
Zip
6944020
Phone
972 3 914 8213
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A